Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
allergan
biotech
clinical trials
3
×
eli lilly
fda
life sciences
national blog main
national top stories
amgen
boston blog main
boston top stories
europe blog main
national
new york blog main
10x genomics
alkermes
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
biogen
biohaven
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
buprenorphine
cadent therapeutics
cariprazine
celgene
centers for disease control and prevention
cgpr
chinook therapeutics
clostridium difficile
community-acquired bacterial pneumonia
dana hilt
daprodustat
What
fda
3
×
treatment
won
adults
alkermes
allergan
antipsychotic
approved
august
benefits
bio
biotech
busy
caveats
class
commonly
days
decisions
designed
devices
drug
drugs
effect
favor
gain
legacy
medicine
medicines
migraine
monday
new
news
nod
nods
offer
opioid
panel
past
pill
prescribed
Language
unset
3
×
Current search:
abbvie
×
unset
×
fda
×
" clinical trials "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More